PerkinElmer and M. D. Anderson Cancer Center Collaborate

Article

PerkinElmer, Inc. (Waltham, Massachusetts) announced an arrangement with the University of Texas M. D. Anderson Cancer Center (Houston, Texas) that will bring the company's Array Comparative Genomic Hybridization technique to the cancer center.

PerkinElmer, Inc. (Waltham, Massachusetts) announced an arrangement with the University of Texas M. D. Anderson Cancer Center (Houston, Texas) that will bring the company's Array Comparative Genomic Hybridization technique to the cancer center. PerkinElmer reportedly will train the facility?s Molecular Genetic Technology students in the technique. The company will also support two student research projects for presentation at genomics and cytogenetics conferences.

Related Videos
Toby Astill | Image Credit: © Thermo Fisher Scientific
Robert Kennedy
Related Content
Business Insight: A Deep Dive into Bruker’s New Mass Spectrometry Division

Business Insight: A Deep Dive into Bruker’s New Mass Spectrometry Division

April 23rd 2024
Article

LCGC International sat down with Jeff Zonderman, senior vice president of Bruker Applied MS at Analytica, to discuss sustainability, PFAS analysis, and the company’s year-old mass spectrometry division.

Ep. 23: Color My World: The Complexities of Color Measurements

Ep. 23: Color My World: The Complexities of Color Measurements

April 1st 2024
Podcast
Site Logo

NanoPak-C All Carbon Solid Phase Extraction (SPE) of Organochlorine Pesticide from Trace Amounts of Environmental Samples

April 23rd 2024
Article

We present a reliable NanoPak-C All Carbon SPE method for extracting and detecting 15 OCPs from small quantities of soil (100 mg) and river water (200 µL) samples.

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

March 7th 2024
Podcast
Powerful Triple Detector for GPC/SEC

Powerful Triple Detector for GPC/SEC

April 22nd 2024
Article
Human liver model on doctor's table, close-up. Treatment of hepatitis, cirrhosis and liver cancer | Image Credit: © Peakstock - stock.adobe.com

Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System

April 22nd 2024
Article

Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.